Contract Management Leader Donates INR 15 Lakhs to Renowned Biomedical Research Institute to Test Anti-Tuberculosis (BCG) Vaccine as COVID-19 Treatment

PUNE, India, May 19, 2020 /PRNewswire/ — Icertis, the leading provider of enterprise contract management in the cloud, today announced a contribution of INR 15 Lakhs to Haffkine Institute to support their efforts in testing an anti-tuberculosis vaccine as a treatment for COVID-19. This donation will cover insurance costs to patients, indemnity to nurses, doctors and investigators, drug supplies, and consumables for patient sample testing in the clinical trials of the Bacillus Calmette-Guérin (BCG) vaccine as a means to neutralize the effects of COVID-19.

Icertis Contributes to Haffkine Institute in Support of the Fight Against COVID-19

At this time, when there are no vaccines to stop the pandemic spread